Showing results (141-150 of 773) with videos related to
Sort By:
Pageof 78
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancerAnn H Partridge, Philip S Wang, Eric P Winer, et al.Journal of the National Cancer Institute|May 2, 2002
Adherence to therapy with oral antineoplastic agentsAnn H Partridge, Jerry Avorn, Philip S Wang, et al.Drug Discovery Today|October 4, 2020
Public funding for transformative drugs: the case of sofosbuvirRachel E Barenie, Jerry Avorn, Frazer A Tessema, et al.Circulation. Cardiovascular Quality and Outcomes|June 15, 2017
Success, Failure, and Transparency in Biomarker-Based Drug Development: A Case Study of Cholesteryl Ester Transfer Protein InhibitorsSpencer Phillips Hey, Jessica M Franklin, Jerry Avorn, et al.American Heart Journal|December 28, 2020
Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort studyBenjamin N Rome, Joshua J Gagne, Jerry Avorn, et al.BMJ (Clinical Research Ed.)|February 26, 2004
Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluationsSebastian Schneeweiss, Malcolm Maclure, Bruce Carleton, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2005
The hepatotoxicity of antifungal medications in bone marrow transplant recipientsMichael A Fischer, Wolfgang C Winkelmayer, Robert H Rubin, et al.Health Affairs (Project Hope)|October 8, 2014
Existing FDA pathways have potential to ensure early access to, and appropriate use of, specialty drugsAaron S Kesselheim, Yongtian Tina Tan, Jonathan J Darrow, et al.Health Affairs (Project Hope)|May 1, 2023
Federal Funding For Discovery And Development Of Costly HIV Drugs Was Far More Than Previously EstimatedFrazer A Tessema, Rachel E Barenie, Jerry Avorn, et al.American Heart Journal|April 1, 2009
Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trialWilliam H Shrank, Niteesh K Choudhry, Daniel H Solomon, et al.Pageof 78